secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001628280-24-027826
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aadi Bioscience shareholders approve director elections, say-on-pay, and auditor ratification at 2024 annual meeting
--------------------------------------------------------------------------------

- Elected Caley Castelein (9.95M for, 1.91M withheld) and Neil Desai (8.17M for, 3.68M withheld) as Class I directors.
- Advisory vote on executive compensation passed with 8.97M for, 2.60M against, 282K abstentions.
- Ratified BDO USA as independent auditor for FY 2024: 13.46M for, 635K against, 1.00M abstentions.
- Total shares represented 15.1M, ~62% of voting power, establishing a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000162828024027826/0001628280-24-027826-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000162828024027826/aadi-20240611.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-027826

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer